Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori

Clinical trial NCT01505127 · COMPLETED

Trial details

NCT number: NCT01505127
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

H. Pylori Infection

Start date: 2012-01-01
Primary completion: 2013-06-01
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.